Clinical Trial: Study of HS235 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF)

U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07123779) titled 'Study of HS235 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF)' on Aug. 08.

Brief Summary: Study of HS235 in Obese Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction Utilizing Ambulatory Pulmonary Artery Pressure Monitoring

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Pulmonary Hypertension Heart Failure With Preserved Ejection Fraction

Intervention: BIOLOGICAL: HS235

Subcutaneous Injection

OTHER: Placebo

Subcutaneous Injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: 35Pharma Inc

Disclaimer: Curate...